template_message_en

Our department’s motto is “Everything we do is for the sake of our patients’ smiles,” and we always keep this in mind as we provide medical care and conduct research with a patient-centered approach. As part of this, we have been developing drug-sensitivity tests using patient-derived colorectal cancer cells in collaboration with the Colon Cancer Project (Kyoto University Hospital-iACT). Recently, we established a consortium comprising six (now seven) universities and five companies to implement innovative personalized cancer treatments with our technologies. Through this approach, we aim to expand the results of our industry-academia collaborative research and deliver outcomes that bring smiles to patients’ faces by predicting the effectiveness of cancer treatments for each patient.